Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   BINA   SPRING 2015 , Volume 20 , Number 3 (80); Page(s) 280 To 285.
 
Paper: 

REVIEW OF NEW GUIDELINES TO SCREEN PATIENTS USING ANTIMALARIA AGENTS

 
 
Author(s):  MALEKIFAR P., NOURINIA R.*, JAVADI F.
 
* OPHTHALMIC RESEARCH CENTER, SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IRAN
 
Abstract: 

Anti-malaria agents including chloroquine and hydroxichloroquine are commonly used for rheumatic diseases e.g. systemic erythematous lupus or rheumatoid arthritis. One of the most important systemic side effects of these agents is ocular side effects (chloroquine toxicity retinopathy). Regarding to importance of early detection of this toxicity, the patients who take these drugs should be evaluated regularly. This article presents the latest recommendations on screening for chloroquine and hydroxychloroquine-induced retinopathy.

 
Keyword(s): ANTI-MALARIA AGENTS, SCREEN, CHLOROQUINE AND HYDROXYCHLOROQUINE RETINOPATHY
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 64
 
Latest on Blog
Enter SID Blog